Ahr locus phenotype in congenic mice influences hepatic and pulmonary DNA adduct levels of 2-amino-3-methylimidazo[4,5-f]quinoline in the absence of cytochrome P450 induction

Molecular Pharmacology

Volumn 49, Issue 5, 1996, Pages 874-881

  Nerurkar, Pratibha V ^a   Schut, Herman A J ^b   Anderson, Lucy M ^a   Riggs, Charles W ^a   Fornwald, Laura W ^c   Davis, Cindy D ^d   Snyderwine, Elizabeth G ^d   Thorgeirsson, Snorri S ^d   Weber, Wendell W ^e   Rice, Jerry M ^a   Levy, Gerald N ^e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c SAIC FREDERICK INC   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; BETA NAPHTHOFLAVONE; CYTOCHROME P450; PHOSPHORUS 32;

ACETYLATOR PHENOTYPE; AMES TEST; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA ADDUCT; DRUG ACETYLATION; ENZYME INDUCTION; FEMALE; HYDROXYLATION; IMMUNOBLOTTING; LIVER; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACETYLATION; ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; DNA ADDUCTS; ENZYME INDUCTION; FEMALE; LIVER; LUNG; MICE; MICE, INBRED STRAINS; PHENOTYPE; QUINOLINES; RECEPTORS, ARYL HYDROCARBON;

EID: 9244259054     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Sugimura, T., M. Nagao, and K. Wakabayashi. Heterocyclic amines in cooked foods: candidates for causation of common cancers. J. Natl. Cancer Inst. 86:2-4 (1994).
2. Snyderwine, E. G., and Battula, N. Selective mutagenic activation by cytochrome P3-450 of carcinogenic arylamines found in food. J. Natl. Cancer Inst. 81:223-227 (1989).
3. Kato, R. Metabolic activation of mutagenic heterocyclic aromatic amines from protein pyrolysates. CRC Crit. Rev. Toxicol. 16:307-348 (1986).
4. Snyderwine, E. G., P. P. Roller, R. H. Adamson, S. Sato, and S. S. Thorgeirsson. Reaction of N-hydroxylamine and N-acetoxy derivatives of 2-amino-3-methylimidazolo[4,5-f]quinoline with DNA: synthesis and identification of N-(deoxyguanosine-8-yl)-IQ. Carcinogenesis 9:1061-1065 (1988).
5. Davis, C. D., H. A. J. Schut, and E. G. Snyderwine. Enzymatic phase II activation of the N-hydroxylamines of IQ, MeIQx and PhIP by various organs of monkeys and rats. Carcinogenesis 14:2091-2096 (1993).
6. Luks, H. J., T. E. Spratt, M. T. Vavrek, S. F. Roland, and J. H. Weisburger. Identification of sulfate and glucuronic acid conjugates of the 5-hydroxy derivative as major metabolites of 2-amino-3-methylimidazo[4,5-f]quinoline in rats. Cancer Res. 49:4407-4411 (1989).
7. Snyderwine, E. G, D. H. Welti, L. B. Fay, H. P. Wurzner, and R. J. Turesky. Metabolism of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in non-human primates undergoing carcinogen bioassay. Chem. Res. Toxicol. 5:843-351 (1992).
8. Poland, A., D. Palen, and E. Glover. Analysis of the four alleles of the murine aryl hydrocarbon receptor. Mol. Pharmacol. 46:915-921 (1994).
9. Dolwick, K. M., J. V. Schmidt, L. A. Carver, H. I. Swanson, and C. A. Bradfield. Cloning and expression of a human Ah receptor cDNA. Mol. Pharmacol. 44:911-917 (1993).
10. Gonzalez, F. J., and H. V. Gelboin. Role of human cytochrome P-450s in risk assessment and susceptibility to environmentally based disease. J. Toxicol. Environ. Health 40:289-308 (1993).
11. 341/803) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles. Drug Metab. Dispos. 22:371-376 (1994).
12. Hein, D. W., M. A. Doll, K. Gray, T. D. Rustan, and R. J. Ferguson. Metabolic activation of N-hydroxy-2-aminofluoreoe and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus. Cancer Res. 53:509-514 (1993).
13. Martell, K. J., K. P. Vatsis, and W. W. Weber. Molecular genetic basis of rapid and slow acetylation in mice. Mol. Pharmacol. 40:218-237 (1991).
14. Weber, W. W. The Acetylator Genes and Drug Response. Oxford University Press, New York (1987).
15. Minchin, R. F., F. F. Kadlubar, and K F. Ilett. Role of acetylation in colorectal cancer. Mutat. Res. 290:35-42 (1993).
16. Lang, N. P., M. A. Butler, J. Massengill, M. Lawson, R. C. Stotts, M. Hauer-Jensen, and F. F. Kadlubar. Rapid metabolic phenotypes for acetyltransferases and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol. Biomarkers Prevent. 3:675-682 (1994).
17. Probst, M. R., M. Blum, I. Fasshauer, D. D'Orazio, U. A. Meyer, and D. Wild. The role of the human acetylation polymorphism in the metabolic activation of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ). Carcinogenesis 13:1713-1717 (1992).
18. Oda, Y., M. Tanaka, and I. Nakanishi. Relation between the occurrence of K-nzs gene point mutations and genotypes of polymorphic N-acetyltransferase in human colorectal carcinomas. Carcinogenesis 15:1366-1369 (1994).
19. Nerurkar, P. V., H. A. J. Schut, L. M. Anderson, C. W. Riggs, E. G. Snyderwine, S. S. Thorgeirsson, W. W. Weber, J. M. Rice, and G. N. Levy. DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in colon, bladder and kidney of congenic mice differing in Ah-responsiveness and N-acetyltransferase genotype. Cancer Res. 55:3043-3049 (1995).
20. Ohgaki, H., H. Hasegawa, T. Kato, M. Suenaga, M. Ubukata, S. Sato, S. Takayama, and T. Sugimura. Carcinogenicity in mice and rats of heterocyclic amines in cooked foods. Environ. Health Perspect. 67:129-134 (1986).
21. Mattano, S. S., R. P. Erickson, M. N. Nesbitt, and W. W. Weber. Linkage of Nat and Es-1 in the mouse and development of strains congenic for N-acetyltransferase. J. Hered. 79:430-433 (1988)
22. Levy, G. N., and W. W. Weber. 2-Aminofluorene-hepatic DNA adducts in congenic mouse lines differing in the Ah responsiveness. Carcinogenesis 11:1233-1235 (1990).
23. Burke, M. D., S. Thompson, C. R. Eicombe, J. Halpert, T. Haaparanta, and R. T. Mayer. Ethoxy-, pentoxy-, and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem. Pharmacol. 34:3337-3345 (1985)
24. Nerurkar, P. V., S. S. Park, P. E. Thomas, R. W. Nims, and R. A. Lubet. Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse. Biochem. Pharmaeol. 46:933-943 (1993).
25. Beebe, L., S. D. Fox, C. W. Riggs, S. S. Park, H. V. Gelboin, H. J. Issaq, and L. M. Anderson. Persistent effects of a single dose of Aroclor 1254 on cytochromes P450IA1 and IIB1 in mouse lung. Toxicol. Appl. Pharmacol. 14:16-24 (1992).
26. Park, S. S., T. Fujino, D. West, F. P. Guengerich, and H. V. Gelboin. Monoclonal antibodies that inhibit enzyme activity of 3-methylcholanthrene-induced cytochrome P-450. Cancer Res. 42:1798-1808 (1982).
27. Davis, C. D., H. A. J. Schut, R. H. Adamson, U. P. Thorgeirsson, S. S. Thorgeirsson, and E. G. Snyderwine. Mutagenic activation of IQ, PhIP and MeIQx by hepatic microsomes from rat, monkey and man: low mutagenic activation of MeIQx in cynomolgus monkeys in vitro reflects low DNA adduct levels in vivo. Carcinogenesis 14:61-65 (1993).
28. Schut, H. A. J., K. L. Putman, and K. Randerath. DNA adduct formation of the carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline in target tissues of the F-344 rat. Cancer Lett. 41:345-352 (1988).
29. Cummings, D. A., and H. A. J. Schut. Inhibitory effect of dietary 4-ipomeanol on DNA adduct formation of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in male CDF1 mice. Carcinogenesis 16: 2523-2529 (1995).
30. Vavrek, M. T., P. Sodoti, J. Reinhardt, and J. H. Weisburger. Effect of enzyme inducers on the metabolism of 2-amino-3-methylimidazo-[4,5-f]quinoline (IQ) in the rat. Cancer Lett. 48:183-188 (1989).
31. Snyderwine E. G., K. Nouso, and H. A. J. Schut. Effect of 3-methylcholanthrene induction on the distribution and DNA adduction of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in F344 rats. Food Chem. Toxicol. 31: 415-423 (1993).
32. Alexander, J., J. A. Holme, H. Wallin, and G. Becher. Characterization of metabolites of the food mutagens 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline formed after incubation with isolated rat liver cells. Chem. Biol. Interact. 72:125-142 (1989).
33. Neumann, H.-G., R. Hammerl, W. Hillesheim, and M. Wildschutte. Role of genotoxic and nongenotoxic effects in multistage carcinogenicity of aromatic amines Environ. Health Perspect. 88:207-211 (1990).
34. Kleman, M. I., E. Overvik, G. G. F. Mason, and J. Gustafsson. In vitro activation of the dioxin receptor to a DNA-binding form by food-borne heterocyclic amines. Carcinogenesis 13:1619-1624 (1992).
35. Fernandez-Salguero, P., T. Pineau, D. M. Hilbert, T. McPhail, S. S. T. Lee, S. Kimura, D. W. Nebert, S. Rudikoff, J. M. Ward, and F. J. Gonzalez. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science (Washington D. C.) 268:722-726 (1995).
36. Hellmold, H., E. Overvik, M. Stromstedt, and J.-A. Gustafsson. Cytoehrome P450 forms in the rodent lung involved in the metabolic activation of food-derived heterocyclic amines. Carcinogenesis 14:1751-1757 (1993).
37. 32P-post-labeling analysis of DNA adducts formed by food-derived heterocyclic amines: evidence for incomplete hydrolysis and a procedure for adduct pattern simplification. Carcinogenesis 15:877-882 (1994).
38. Zu, H.-X., and H. A. J. Schut. Sex differences in the formation and persistence of DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in CDF1 mice. Carcinogenesis 12:2163-2168 (1991).
39. Hall, M., M. N. She, D. Wild, I. Fasshauer, A. Hewer, and D. H. Phillips. Tissue distribution of DNA adducts in CDF1 mice fed 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ). Carcinogenesis 11:1005-1011 (1990).
40. s slow acetylator congenic mice. Drug Metab. Dispos. 21:1057-1063 (1993).